Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD)

• Status: Recruiting
• Trial end date: 2024-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Wahsed microbiota transplantation (WMT) is a novel and promising therapeutic method for Chronic Kidney Disease (CKD). This clinical trail aims to evaluate the efficacy and safety of WMT in the treatment of CKD.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Second Hospital of Nanjing Medical University

Criteria

Inclusion Criteria:

• Being diagnosed with chronic kidney disease without WMT in the past three months

• Able to tolerate colonoscopy

• Receiving rescue FMT from the China Microbiota Transplantation System

• Suitable and compatible with WMT treatment

• Patients who can fully understand the content of informed consent for this trial and voluntarily sign a written informed consent form

• Able to receive follow-up examinations, follow-up examinations and retain specimens on time

Exclusion Criteria:

• Patients will be excluded from the analysis if they are not followed up for at least 12 weeks post-FMT

• Antibiotics or probiotics within 4 weeks prior to enrollment

• Patients with anxiety, depression, mental or legal disabilities

• Patients with fulminant type, massive bloody stools, and severe illness unable to tolerate colonoscopy

• Other patients deemed unsuitable for enrollment by the investigator